Literature DB >> 7243233

Tamoxifen retinopathy. A clinicopathologic report.

M I Kaiser-Kupfer, C Kupfer, M M Rodrigues.   

Abstract

A 57-year-old woman with metastatic breast carcinoma treated by surgery and high-dosage tamoxifen chemotherapy developed tamoxifen retinopathy characterized by white superficial refractile retinal lesions primarily in the paramacular area. At postmortem examination, the retinal lesions seen clinically were identified as being 3 to 10 microns in diameter in the macular area, and 30 to 35 microns in diameter in the paramacular area. The lesions were confined to the nerve fiber layer and inner plexiform layer and stained positive with stains for glycosaminoglycans. Electron microscopic examination revealed that the smaller lesions were intracellular and the larger lesions extracellular. The lesions were composed of randomly oriented branching electron dense 6-nm filaments accompanied by occasional electron dense coated vesicles measuring 60 to 70 nn in diameter. The lesions appeared to be occurring in axons and seemed to represent products of axonal degeneration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7243233     DOI: 10.1016/s0161-6420(81)35071-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

Review 1.  The differential diagnosis of crystals in the retina.

Authors:  F Nadim; H Walid; J Adib
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Tamoxifen retinopathy: a rare but serious complication.

Authors:  C R Bentley; G Davies; W A Aclimandos
Journal:  BMJ       Date:  1992-02-22

3.  Electrophysiological evaluation of visual pathways in paclitaxel-treated patients.

Authors:  V Scaioli; A Caraceni; C Martini; S Curzi; G Capri; G Luca
Journal:  J Neurooncol       Date:  2005-08-25       Impact factor: 4.130

4.  Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions.

Authors:  S I Davidson; I G Rennie
Journal:  Med Toxicol       Date:  1986 May-Jun

5.  Tamoxifen therapy conveys increased risk of developing a macular hole.

Authors:  Brendan G Cronin; Christopher K Lekich; Robert D Bourke
Journal:  Int Ophthalmol       Date:  2006-09-15       Impact factor: 2.031

6.  Microcystoid maculopathy associated with tamoxifen use diagnosed by high-resolution fourier-domain optical coherence tomography.

Authors:  Susanna S Park; Robert J Zawadzki; Steven N Truong; Stacey S Choi; John S Werner
Journal:  Retin Cases Brief Rep       Date:  2009

Review 7.  Prevention and management of drug-induced peripheral neuropathy.

Authors:  L L Olesen; T S Jensen
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

8.  Retinal function in patients treated with tamoxifen.

Authors:  Sung Eun Song Watanabe; Adriana Berezovsky; Márcia Motono; Paula Yuri Sacai; Josenilson Martins Pereira; Juliana Maria Ferraz Sallum; Luiz Henrique Gebrim; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2010-04       Impact factor: 2.379

9.  HYPERREFLECTIVE DEPOSITION IN THE BACKGROUND OF ADVANCED STARGARDT DISEASE.

Authors:  Lyam Ciccone; Winston Lee; Jana Zernant; Koji Tanaka; Kaspar Schuerch; Stephen H Tsang; Rando Allikmets
Journal:  Retina       Date:  2018-11       Impact factor: 4.256

Review 10.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.